BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33319313)

  • 1. Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1.
    Sievers P; Sill M; Blume C; Tauziede-Espariat A; Schrimpf D; Stichel D; Reuss DE; Dogan H; Hartmann C; Mawrin C; Hasselblatt M; Stummer W; Schick U; Hench J; Frank S; Ketter R; Schweizer L; Schittenhelm J; Puget S; Brandner S; Jaunmuktane Z; Küsters B; Abdullaev Z; Pekmezci M; Snuderl M; Ratliff M; Herold-Mende C; Unterberg A; Aldape K; Ellison DW; Wesseling P; Reifenberger G; Wick W; Perry A; Varlet P; Pfister SM; Jones DTW; von Deimling A; Sahm F;
    Acta Neuropathol; 2021 Feb; 141(2):281-290. PubMed ID: 33319313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas.
    Smith MJ; Wallace AJ; Bennett C; Hasselblatt M; Elert-Dobkowska E; Evans LT; Hickey WF; van Hoff J; Bauer D; Lee A; Hevner RF; Beetz C; du Plessis D; Kilday JP; Newman WG; Evans DG
    J Pathol; 2014 Dec; 234(4):436-40. PubMed ID: 25143307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMARCE1 mutation screening in classification of clear cell meningiomas.
    Smith MJ; Ahn S; Lee JI; Bulman M; Plessis DD; Suh YL
    Histopathology; 2017 Apr; 70(5):814-820. PubMed ID: 27891692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of SMARCE1 expression is a specific diagnostic marker of clear cell meningioma: a comprehensive immunophenotypical and molecular analysis.
    Tauziede-Espariat A; Parfait B; Besnard A; Lacombe J; Pallud J; Tazi S; Puget S; Lot G; Terris B; Cohen J; Vidaud M; Figarella-Branger D; Monnien F; Polivka M; Adle-Biassette H; Varlet P
    Brain Pathol; 2018 Jul; 28(4):466-474. PubMed ID: 28474749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric clear cell meningioma involving the middle cranial fossa in the context of NF2 and SMARCE1 mutations.
    Libert DM; Prayson RA
    Ann Diagn Pathol; 2020 Jun; 46():151516. PubMed ID: 32311644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of genetic counseling and screening for people with pathogenic SMARCE1 variants: A family study.
    Shoakazemi A; Hewitt A; Smith MJ; du Plessis D; Thomas O; Stivaros SM; Deniz K; Hammerbeck-Ward C; Rutherford SA; King AT; Evans DG
    Am J Med Genet A; 2021 Feb; 185(2):561-565. PubMed ID: 33185983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
    Sahm F; Schrimpf D; Stichel D; Jones DTW; Hielscher T; Schefzyk S; Okonechnikov K; Koelsche C; Reuss DE; Capper D; Sturm D; Wirsching HG; Berghoff AS; Baumgarten P; Kratz A; Huang K; Wefers AK; Hovestadt V; Sill M; Ellis HP; Kurian KM; Okuducu AF; Jungk C; Drueschler K; Schick M; Bewerunge-Hudler M; Mawrin C; Seiz-Rosenhagen M; Ketter R; Simon M; Westphal M; Lamszus K; Becker A; Koch A; Schittenhelm J; Rushing EJ; Collins VP; Brehmer S; Chavez L; Platten M; Hänggi D; Unterberg A; Paulus W; Wick W; Pfister SM; Mittelbronn M; Preusser M; Herold-Mende C; Weller M; von Deimling A
    Lancet Oncol; 2017 May; 18(5):682-694. PubMed ID: 28314689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas.
    Smith MJ; O'Sullivan J; Bhaskar SS; Hadfield KD; Poke G; Caird J; Sharif S; Eccles D; Fitzpatrick D; Rawluk D; du Plessis D; Newman WG; Evans DG
    Nat Genet; 2013 Mar; 45(3):295-8. PubMed ID: 23377182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-grade meningiomas: biology and implications.
    Bi WL; Prabhu VC; Dunn IF
    Neurosurg Focus; 2018 Apr; 44(4):E2. PubMed ID: 29606053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric intracranial clear cell meningioma associated with a germline mutation of SMARCE1: a novel case.
    Raffalli-Ebezant H; Rutherford SA; Stivaros S; Kelsey A; Smith M; Evans DG; Kilday JP
    Childs Nerv Syst; 2015 Mar; 31(3):441-7. PubMed ID: 25249420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SMARCE1-related meningiomas: A clear example of cancer predisposing syndrome.
    Fiorentini E; Giunti L; Di Rita A; Peraio S; Fonte C; Caporalini C; Buccoliero AM; Censullo ML; Gori G; Noris A; Pasquariello R; Battini R; Pavone R; Giordano F; Giglio S; Rinaldi B
    Eur J Med Genet; 2023 Jul; 66(7):104784. PubMed ID: 37164167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A heritable form of SMARCE1-related meningiomas with important implications for follow-up and family screening.
    Gerkes EH; Fock JM; den Dunnen WF; van Belzen MJ; van der Lans CA; Hoving EW; Fakkert IE; Smith MJ; Evans DG; Olderode-Berends MJ
    Neurogenetics; 2016 Apr; 17(2):83-9. PubMed ID: 26803492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SMARCE1 mutations in pediatric clear cell meningioma: case report.
    Evans LT; Van Hoff J; Hickey WF; Smith MJ; Evans DG; Newman WG; Bauer DF
    J Neurosurg Pediatr; 2015 Sep; 16(3):296-300. PubMed ID: 26114992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of SMARCE1 in the diagnosis of clear cell meningioma].
    Zhang L; Yao ZG; Lian F; Wang DZ; Chen YP; Cai SS; Zhang S; Wang XF
    Zhonghua Bing Li Xue Za Zhi; 2020 Mar; 49(3):234-238. PubMed ID: 32187894
    [No Abstract]   [Full Text] [Related]  

  • 15. Distinct Expression Patterns of Carbonic Anhydrase IX in Clear Cell, Microcystic, and Angiomatous Meningiomas.
    Chkheidze R; Cimino PJ; Hatanpaa KJ; White CL; Ferreira M; Piccirillo SGM; Li L; Rajaram S; Nyagilo JO; Burns DK; Raisanen JM; Cai C
    J Neuropathol Exp Neurol; 2019 Dec; 78(12):1081-1088. PubMed ID: 31589317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new amplicon-based gene panel for next generation sequencing characterization of meningiomas.
    Mawrin C; Koch R; Waldt N; Sandalcioglu IE; Braunsdorf WEK; Warnke JP; Goehre F; Meisel HJ; Ewald C; Neyazi S; Schüller U; Kirches E
    Brain Pathol; 2022 Mar; 32(2):e13046. PubMed ID: 35213080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lumbar clear cell meningioma mimicking schwannoma 7 years after resection of the same type of intracranial tumor: a case report.
    Horikawa T; Nozawa S; Suzui N; Yamada K; Iwai C; Akiyama H
    J Med Case Rep; 2024 Feb; 18(1):82. PubMed ID: 38321548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous Anatomy Influence on the Approach Selection of a Petroclival Clear Cell Meningioma With Associated Multiple Spinal Meningiomas: 2-Dimensional Operative Video.
    Essayed WIBN; Mooney MA; Al-Mefty O
    Oper Neurosurg (Hagerstown); 2021 May; 20(6):E426-E427. PubMed ID: 33928378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence.
    Katz LM; Hielscher T; Liechty B; Silverman J; Zagzag D; Sen R; Wu P; Golfinos JG; Reuss D; Neidert MC; Wirsching HG; Baumgarten P; Herold-Mende C; Wick W; Harter PN; Weller M; von Deimling A; Snuderl M; Sen C; Sahm F
    Acta Neuropathol; 2018 Jun; 135(6):955-963. PubMed ID: 29627952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Genetic Predisposition With Solitary Schwannoma or Meningioma in Children and Young Adults.
    Pathmanaban ON; Sadler KV; Kamaly-Asl ID; King AT; Rutherford SA; Hammerbeck-Ward C; McCabe MG; Kilday JP; Beetz C; Poplawski NK; Evans DG; Smith MJ
    JAMA Neurol; 2017 Sep; 74(9):1123-1129. PubMed ID: 28759666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.